Skip to content
Équilibre Biopharmaceuticals Corp
  • Careers
  • Contact Us
  • About Us
    • Our Company
    • Leadership
    • Board of Directors
  • Our Science
  • Therapeutic Areas
    • Seizure Disorders
    • Traumatic Brain Injury
  • Clinical Trials
  • News & Publications
Menu

News & Publications

News & Publications

Home > News & Publications
  •     
  • Print
Home > News & Publications

News & Publications

Equilibre Biopharmaceuticals Announces Positive Topline Results from Phase 2 Clinical Trial of EQU-001 (NCT05063877) for Safety, Tolerability and Preliminary Efficacy as Adjunctive Therapy for Focal Seizures in Adults with Epilepsy

  • Équilibre Biopharmaceuticals Corp.
    430 East 29th Street
    New York, NY 10016
  • info@eqneuro.com
  • +1 332 400 0300

Follow Us

  • About Us
  • Our Company
  • Leadership
  • Board of Directors
  • Therapeutic Areas
  • Seizure Disorders
  • Traumatic Brain Injury
  • Our Science
  • Clinical Trials
  • News & Publications
  • Careers
© Copyright 2023 Équilibre Biopharmaceuticals Corp. All Rights Reserved
Site Map | Terms of Use/Privacy
Website by Axxiem
Scroll to top